HIGHLIGHTS
- who: Minghui Li from the Capital Medical University, China have published the paper: Dynamic changes of cytokine profiles and virological markers during 48 weeks of entecavir treatment for HBeAg-positive chronic hepatitis B, in the Journal: (JOURNAL)
- what: The aim of this study is to explore the changes in serology, virology, and cytokine indexes in patients with HBeAg-positive CHB during the 48-week ETV treatment. In this study, compared with the incomplete virus response group, the complete virus response group had lower HBV DNA load, lower HBeAg and HBsAg levels, lower IL-10 level . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.